Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 5
2010 2
2011 1
2012 1
2013 5
2014 4
2015 3
2016 4
2017 2
2018 4
2019 2
2020 2
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative. COVID-19 Host Genetics Initiative. Nature. 2021 Dec;600(7889):472-477. doi: 10.1038/s41586-021-03767-x. Epub 2021 Jul 8. Nature. 2021. PMID: 34237774 Free PMC article.
American Cancer Society Colorectal Cancer Survivorship Care Guidelines.
El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, Cannady RS, Wong SL, Rose J, Barbour AL, Stein KD, Sharpe KB, Brooks DD, Cowens-Alvarado RL. El-Shami K, et al. Among authors: barbour al. CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55. doi: 10.3322/caac.21286. Epub 2015 Sep 8. CA Cancer J Clin. 2015. PMID: 26348643 Free PMC article. Review.
Clinical pharmacokinetics and pharmacodynamics of tigecycline.
Barbour A, Schmidt S, Ma B, Schiefelbein L, Rand KH, Burkhardt O, Derendorf H. Barbour A, et al. Clin Pharmacokinet. 2009;48(9):575-84. doi: 10.2165/11317100-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19725592 Review.
PK/PD: new insights for antibacterial and antiviral applications.
Schmidt S, Barbour A, Sahre M, Rand KH, Derendorf H. Schmidt S, et al. Among authors: barbour a. Curr Opin Pharmacol. 2008 Oct;8(5):549-56. doi: 10.1016/j.coph.2008.06.010. Epub 2008 Jul 30. Curr Opin Pharmacol. 2008. PMID: 18625339 Review.
Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib.
Barbour AM, Rockich K, Cimino E, Zhou G, Leonetti-Whalen C, Chen X, Yeleswaram S, Epstein N, Punwani N. Barbour AM, et al. J Clin Pharmacol. 2021 Jul;61(7):954-960. doi: 10.1002/jcph.1814. Epub 2021 Jan 28. J Clin Pharmacol. 2021. PMID: 33434286
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib.
Srinivas N, Barbour AM, Epstein N, Zhou G, Petusky S, Xun Z, Yuska B, Marbury T, Chen X, Yeleswaram S, Punwani N. Srinivas N, et al. Among authors: barbour am. J Clin Pharmacol. 2020 Aug;60(8):1022-1029. doi: 10.1002/jcph.1601. Epub 2020 Mar 9. J Clin Pharmacol. 2020. PMID: 32149388 Free PMC article.
36 results